L. Avrahami

发表

VIVO AND IN VITRO STUDIES IN in the Alzheimer Disease Mouse Model : Mammalian Target of Rapamycin Activity Restores Lysosomal Acidification and -Amyloid Pathology and β Ameliorates Inhibition of Glycogen Synthase Kinase-3 Molecular Bases of Disease:

H. Eldar-Finkelman, R. Vassar, L. Avrahami, 2013 .

Inhibition of Glycogen Synthase Kinase-3 Ameliorates β-Amyloid Pathology and Restores Lysosomal Acidification and Mammalian Target of Rapamycin Activity in the Alzheimer Disease Mouse Model

H. Eldar-Finkelman, R. Vassar, L. Avrahami, 2012, The Journal of Biological Chemistry.

Guidelines for the use and interpretation of assays formonitoring autophagy (3rd edition)

Sangeeta Khare, Xin Qi, Ying Wang, 2016 .

GSK-3 inhibition: achieving moderate efficacy with high selectivity.

M. Eisenstein, H. Eldar-Finkelman, L. Avrahami, 2013, Biochimica et biophysica acta.

GSK-3 and lysosomes meet in Alzheimer’s disease

H. Eldar-Finkelman, L. Avrahami, 2013, Communicative & integrative biology.

Autosomal recessive ichthyosis with hypotrichosis syndrome: further delineation of the phenotype

J. van Marle, L. Avrahami, M. Shohat, 2008, Clinical genetics.

Combined regulation of mTORC1 and lysosomal acidification by GSK-3 suppresses autophagy and contributes to cancer cell growth

H. Eldar-Finkelman, L. Avrahami, A. Katz, 2014, Oncogene.

A unique type of GSK-3 inhibitor brings new opportunities to the clinic

M. Eisenstein, H. Eldar-Finkelman, L. Avrahami, 2016, Science Signaling.

Selective loss of glycogen synthase kinase‐3α in birds reveals distinct roles for GSK‐3 isozymes in tau phosphorylation

S. Pietrokovski, J. Woodgett, H. Eldar-Finkelman, 2011, FEBS letters.

GSK-3-TSC axis governs lysosomal acidification through autophagy and endocytic pathways.

C. Bucci, H. Eldar-Finkelman, L. Avrahami, 2020, Cellular signalling.

Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

Sara W. Bird, Erinna F. Lee, Michael D. Kim, 2016 .

Editorial :Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). DOI: 10.1080/15548627.2015.1100356;WOS:000373595400001; 2-s2.0-85013763791&;PMID: 26799652

Lee, Duchen, Izzo, 2016 .

Physiological expression of mutated TAU impaired astrocyte activity and exacerbates β-amyloid pathology in 5xFAD mice

H. Eldar-Finkelman, L. Avrahami, D. Farfara, 2023, Journal of Neuroinflammation.

Combined regulation of mTORC1 and lysosomal acidification by GSK-3 suppresses autophagy and contributes to cancer cell growth

H. Eldar-Finkelman, L. Avrahami, A. Katz, 2014, Oncogene.

GSK-3 inhibition: achieving moderate efficacy with high selectivity.

M. Eisenstein, H. Eldar-Finkelman, L. Avrahami, 2013, Biochimica et biophysica acta.